However, it would be valuable to assess the impact of NFATc2 inhibition, regarding its impact upon the cell cycle, at an earlier timepoint using small molecule inhibition, in order to evaluate its immediate effects and delineate its functional effects within AML cells. This evidence concerns the gene NFATC2 and acute myeloid leukemia.